Validation of the Cozart® microplate EIA for cocaine and metabolites in oral fluid

Journal of Analytical Toxicology

Volumn 28, Issue 6, 2004, Pages 498-503

  Cooper, Gail ^a,c   Wilson, Lisa ^a   Reid, Claire ^a   Baldwin, Dene ^a   Hand, Chris ^a   Spieher, Vina ^b  

^a Cozart plc ^*  (United Kingdom)

^b Spiehler and Associates   (United States)

^c Cozert plc ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; BENZOYLECGONINE; COCAINE; DRUG METABOLITE; HEMOGLOBIN; METHADONE; NARCOTIC AGENT;

BODY FLUID; COCAINE DEPENDENCE; COFFEE; CONFERENCE PAPER; CONTROLLED STUDY; CRIMINAL JUSTICE; DRUG ABUSE; DRUG DEPENDENCE; DRUG DEPENDENCE TREATMENT; ENZYME IMMUNOASSAY; FOOD INTAKE; GAS CHROMATOGRAPHY; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MASS SPECTROMETRY; METHADONE TREATMENT; MOUTH CAVITY; MOUTH HYGIENE; ORAL FLUID; ORANGE JUICE; TEA; WORKPLACE; ALGORITHM; ANTIBODY SPECIFICITY; ARTICLE; CHEMISTRY; CROSS REACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FOOD; INSTRUMENTATION; LABORATORY DIAGNOSIS; MASS FRAGMENTOGRAPHY; METABOLISM; METHODOLOGY; OPIATE ADDICTION; REPRODUCIBILITY; SALIVA; SMOKING; SUBSTANCE ABUSE; VALIDATION STUDY;

ALGORITHMS; ANTIBODY SPECIFICITY; COCAINE; COCAINE-RELATED DISORDERS; CROSS REACTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; FOOD; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HEMOGLOBINS; HUMANS; IMMUNOENZYME TECHNIQUES; METHADONE; NARCOTICS; OPIOID-RELATED DISORDERS; REPRODUCIBILITY OF RESULTS; SALIVA; SMOKING; SUBSTANCE ABUSE DETECTION;

EID: 4344687303     PISSN: 01464760     EISSN: None     Source Type: Journal    
DOI: 10.1093/jat/28.6.498     Document Type: Conference Paper

References (16)

1. O.R. Idowu and B. Caddy. A review of the use of saliva in the forensic detection of drugs and other chemicals. J. Forensic Sci. Soc. 22: 123-135 (1982).
2. E.J. Cone, K. Kumor, L.K. Thompson, and M. Sherer. Correlation of saliva cocaine levels with plasma levels and with pharmacologic effects after intravenous cocaine administration in human subjects. J. Anal. Toxicol. 12: 200-206 (1988).
3. J. Evans. The evaluation and introduction into forensic casework of a commercially available non-isotopic immunoassay for drugs of abuse. TIAFT XXXV Annual Meeting Proceedings, Padova, Italy, 1997.
4. H. Kaferstein and G. Sticht. Comparison of the MTP immunoassay with EMIT in blood screening for drugs. Arch. Kriminol. 202: 165-172 (1998).
5. H. Kaferstein and G. Sticht. Results of immunochemical and chromatographic investigations of blood samples in suspected drug abuse-1. Report: opiates, cocaine, cannabinoids and amphetamines. Rechtsmedizin 8: 173-177 (1998).
6. S.W. Toennes and G. Kauert. Immunochemical screening of serum samples: comparison of the cannabinoid and opiate assays Mahsan MTP and Abbott FPIA with control by gas chromatography mass spectrometry. Rechtsmedizin 10: 71-75 (2000).
7. L. Kroener, F. Musshoff, and B. Madea. Evaluation of immunochemical drug screening. A retrospective optimization of cutoff levels after confirmation analysis on GC-MS and HPLC-DAD. J. Anal. Toxicol. 27: 205-212 (2003).
8. L. Tsanaclis, D. Edwards and J. Wicks. Hair analysis for detection of drugs: A retrospective review of data obtained in the routine practice of a specialist laboratory. Proceedings of the 2001 Meeting of TIAFT, Prague, Czech Republic, 2002.
9. V. Spiehler. Hair analysis by immunological methods from the beginning to 2000. Forensic Sci. Int. 107: 249-259 (2000).
10. G. Cooper, L. Wilson, C. Reid, D. Baldwin, C. Hand, and V. Spiehler. Validation of the Cozart® microplate ELISA for detection of opiates in hair. J. Anal. Toxicol. 27: 581-586 (2003).
11. A.J. Barnes, I. Kim, R. Schepers, E.T. Moolchan, L. Wilson, G. Cooper, C. Reid, C. Hand, and M.A. Huestis. Sensitivity, specificity and efficiency in detecting opiates in oral fluid with the Cozart® opiate microplate EIA and GC-MS following controlled codeine administration. J. Anal. Toxicol. 27: 402-406 (2003).
12. E.A. Kolbrich, I. Kim, R. A.J. Barnes, E.T. Moolchan, L. Wilson, G. Cooper, C. Reid, D. Baldwin, C. Hand, and M.A. Huestis. Cozart® RapiScan oral fluid drug testing system: an evaluation of sensitivity, specificity and efficiency for cocaine detection compared with ELISA and GC-MS following controlled cocaine administration. J. Anal. Toxicol. 27: 407-411 (2003).
13. E.J. Cone. Saliva testing for drugs of abuse. Ann. New York Acad. Sci. 694: 91-127 (1993).
14. W. Schraum, R.H. Smith, P.A. Craig, and D.A. Kidwell. Drugs of abuse in saliva: a review. J. Anal. Toxicol. 16: 1-9 (1992).
15. A.J. Jenkins, J.M. Oyler, and E.J. Cone. Comparison of heroin and cocaine concentrations in saliva with concentrations in blood and plasma. J. Anal. Toxicol. 19: 359-374 (1995).
16. I. Kim, A.J. Barnes, R. Schepers, E.T. Moolchan, L. Wilson, G. Cooper, C. Reid, C. Hand, and M.A. Huestis. Sensitivity and specificity of the Cozart microplate EIA cocaine oral fluid at proposed screening and confirmation cutoffs. Clin Chem. 49(9): 1498-1503 (2003).